A phase I trial of OBE 022 in healthy volunteers

Trial Profile

A phase I trial of OBE 022 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 01 Mar 2018

At a glance

  • Drugs OBE 022 (Primary)
  • Indications Preterm labour
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 01 Mar 2018 Clinical safety and exposure data will be presented at the 65th Annual Meeting of the Society for Reproductive Investigation (SRI), according to an ObsEva SA media release.
    • 11 Sep 2017 According to an ObsEva media release, cardiac safety data from this trial will be presented at the 2017 Annual Meeting of the American College of Clinical Pharmacology (ACCP).
    • 13 Jan 2017 Results published in an ObsEva media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top